Cetuximab and Radiation Therapy in Head and Neck Cancer

Diseases and Conditions Researched

Head and Neck Cancer


Participation Guidelines

Age: 18 Years and older
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: Yale
Study HIC#: 0811004509